Welcome to Johns Hopkins Health Alerts!

"Johns Hopkins Health Alerts is an excellent site and I have recommended it to several of my friends. Thanks again, and keep up the good work!"
  • - D. Ambrosio


This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging.

Get the latest news sent straight to your inbox for FREE. Check all the boxes below for the topics that interest you.
We value your privacy and will never rent your email address

Johns Hopkins Health Alert

Medications for BPH: What Works Best?

Comments (1)

The prescription drugs available for treating benign prostatic hyperplasia (BPH, also known as enlarged prostatic enlargement or BPE) fall into two categories: alpha-blockers and 5-alpha-reductase inhibitors. Although research suggests that 30 to 60 percent of men will be helped by these drugs, it's not possible to predict which men will benefit from them or which drug will work best for which person.

It's estimated that 1.5 million American men are currently on a lifetime regimen of prostate medications. To date, no medication offers a cure for BPH -- the drugs only diminish BPH symptoms. Once any medication is stopped, BPH symptoms will recur.

  • How do you decide whether to use an alpha-blocker or a 5-alpha-reductase inhibitor for treating bothersome BPH symptoms?

When the patient is symptomatic, the best and fastest way to help him is generally with an alpha-blocker. There is no difference in response rates based on a patient's age, symptom severity, flow rate, prostate volume or PSA. The drugs all seem to work equally well.

  • Is there any benefit to combination therapy -- taking an alpha-blocker and a 5-alpha-reductase inhibitor at the same time? 

The data from the multicenter MTOPS (Medical Therapy Of Prostatic Symptoms) trial reported very clearly that combination therapy is the best way to treat BPH symptoms as well as to prevent the progression of the disease.

Over a five-year span, this NIH-sponsored study of 3,000 men with symptomatic BPH compared the effects of Proscar, Cardura, the combination of the two and placebo. It was the largest, longest study of its kind. Results from the 17-center study showed that combination therapy with Cardura and Proscar slowed the progression of signs and symptoms of BPH to a much greater extent than monotherapy with either drug.

Posted in Enlarged Prostate on July 10, 2012


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Enlarged Prostate Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


You can get some advices from other people. It's better to learn from their experiences. Casino Themed Party

Posted by: vitalybrontoze | February 13, 2013 2:46 AM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

Customer Service

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML